Institute of Reproductive and Developmental Biology, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom (Drs Mylrea-Foley and Lees); Department of Fetal Medicine, Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom (Drs Mylrea-Foley and Lees).
Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, United Kingdom (Dr Napolitano); Fetal Medicine Unit, University College London Hospitals NHS Foundation Trust, London, United Kingdom (Dr Napolitano).
Am J Obstet Gynecol MFM. 2023 Nov;5(11):101117. doi: 10.1016/j.ajogmf.2023.101117. Epub 2023 Aug 5.
Criteria for diagnosis of fetal growth restriction differ widely according to national and international guidelines, and further heterogeneity arises from the use of different biometric and Doppler reference charts, making the diagnosis of fetal growth restriction highly variable.
This study aimed to compare fetal growth restriction definitions between Delphi consensus and Society for Maternal-Fetal Medicine definitions, using different standards/charts for fetal biometry and different reference ranges for Doppler velocimetry parameters.
From the TRUFFLE 2 feasibility study (856 women with singleton pregnancy at 32 to 36 weeks of gestation and at risk of fetal growth restriction), we selected 564 women with available mid-pregnancy biometry. For the comparison, we used standards/charts for estimated fetal weight and abdominal circumference from Hadlock, INTERGROWTH-21, and GROW and Chitty. Percentiles for umbilical artery pulsatility index and its ratios with middle cerebral artery pulsatility index were calculated using Arduini and Ebbing reference charts. Sensitivity and specificity for low birthweight and adverse perinatal outcome were evaluated.
Different combinations of definitions and reference charts identified substantially different proportions of fetuses within our population as having fetal growth restriction, varying from 38% (with Delphi consensus definition, INTERGROWTH-21 biometric standards, and Arduini Doppler reference ranges) to 93% (with Society for Maternal-Fetal Medicine definition and Hadlock biometric standards). None of the different combinations tested appeared effective, with relative risk for birthweight <10th percentile between 1.4 and 2.1. Birthweight <10th percentile was observed most frequently when selection was made with the GROW/Chitty charts, slightly less with the Hadlock standard, and least frequently with the INTERGROWTH-21 standard. Using the Ebbing Doppler reference ranges resulted in a far higher proportion identified as having fetal growth restriction compared with the Arduini Doppler reference ranges, whereas Delphi consensus definition with Ebbing Doppler reference ranges produced similar results to those of the Society for Maternal-Fetal Medicine definition. Application of Delphi consensus definition with Arduini Doppler reference ranges was significantly associated with adverse perinatal outcome, with any biometric standards/charts. The Society for Maternal-Fetal Medicine definition could not accurately detect adverse perinatal outcome irrespective of estimated fetal weight standard/chart used.
Different combinations of fetal growth restriction definitions, biometry standards/charts, and Doppler reference ranges identify different proportions of fetuses with fetal growth restriction. The difference in adverse perinatal outcome may be modest, but can have a significant impact in terms of rate of intervention.
根据国家和国际指南,胎儿生长受限的诊断标准差异很大,进一步的异质性源于使用不同的生物测量和多普勒参考图表,使得胎儿生长受限的诊断高度可变。
本研究旨在比较德尔菲共识和母胎医学会定义的胎儿生长受限定义,使用不同的胎儿生物测量标准/图表和不同的多普勒血流速度参数参考范围。
从 TRUFFLE 2 可行性研究(856 名 32 至 36 孕周单胎妊娠且有胎儿生长受限风险的妇女)中,我们选择了 564 名具有中孕期生物测量值的妇女。为了进行比较,我们使用了 Hadlock、INTERGROWTH-21 和 GROW 及 Chitty 的估计胎儿体重和腹围标准/图表。使用 Arduini 和 Ebbing 参考图表计算脐动脉搏动指数及其与大脑中动脉搏动指数比值的百分位数。评估了低出生体重和不良围产期结局的灵敏度和特异性。
不同的定义和参考图表组合在我们的人群中确定了具有胎儿生长受限的胎儿比例存在显著差异,从 38%(采用德尔菲共识定义、INTERGROWTH-21 生物测量标准和 Arduini 多普勒参考范围)到 93%(采用母胎医学会定义和 Hadlock 生物测量标准)。测试的不同组合均不有效,出生体重<第 10 百分位数的相对风险在 1.4 至 2.1 之间。当使用 GROW/Chitty 图表进行选择时,观察到<第 10 百分位数的出生体重最频繁,其次是 Hadlock 标准,最少是 INTERGROWTH-21 标准。与 Arduini 多普勒参考范围相比,使用 Ebbing 多普勒参考范围识别出具有胎儿生长受限的比例要高得多,而使用 Ebbing 多普勒参考范围的德尔菲共识定义与母胎医学会定义产生的结果相似。应用德尔菲共识定义和 Arduini 多普勒参考范围与任何生物测量标准/图表均与不良围产期结局显著相关。无论使用何种估计胎儿体重标准/图表,母胎医学会定义都无法准确检测到不良围产期结局。
胎儿生长受限定义、生物测量标准/图表和多普勒参考范围的不同组合可识别出不同比例的胎儿存在胎儿生长受限。不良围产期结局的差异可能很小,但在干预率方面可能会产生重大影响。